MEDICAL TREATMENT

Details for Australian Patent Application No. 2003202075 (hide)

Owner LORANTIS LIMITED

Inventors CHAMPION, Brian, Robert; FALCIANI, Francesco; HAYWARD, Penelope, Caroline; MASLEN, Gareth, Llewellyn

Pub. Number AU-A-2003202075

PCT Number PCT/GB03/00303

PCT Pub. Number WO2003/062273

Priority 0201674.9 25.01.02 GB

Filing date 27 January 2003

Wipo publication date 2 September 2003

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

A61K 038/17 Medicinal preparations containing peptides - from animals

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 015/00 Mutation or genetic engineering

C07K 014/715 Peptides having more than 20 amino acids

C07K 014/705 Peptides having more than 20 amino acids

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 0201674.9 25.01.02 GB

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003202075

14 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202076-COMPOUNDS USEFUL AS A3 ADENOSINE RECEPTOR AGONISTS

2003202074-FORMULATION FOR THE ADMINISTRATION OF MEDICINAL SUBSTANCES